This poster, presented at the Society of Immunotherapy for Cancer Annual Meeting 2022, illustrates gaps in awareness of and confidence in using LAG-3 therapies for cancer among healthcare professionals.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.